Larimar Therapeutics's total assets for Q4 2024 were $200.22M, a decrease of -8.58% from the previous quarter. LRMR total liabilities were $28.41M for the fiscal quarter, a 37.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.